These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17224308)

  • 1. A 6-month longitudinal study of bone mineral density with antiepileptic drug monotherapy.
    Kim SH; Lee JW; Choi KG; Chung HW; Lee HW
    Epilepsy Behav; 2007 Mar; 10(2):291-5. PubMed ID: 17224308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone health in young women with epilepsy after one year of antiepileptic drug monotherapy.
    Pack AM; Morrell MJ; Randall A; McMahon DJ; Shane E
    Neurology; 2008 Apr; 70(18):1586-93. PubMed ID: 18443309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine.
    Mintzer S; Boppana P; Toguri J; DeSantis A
    Epilepsia; 2006 Mar; 47(3):510-5. PubMed ID: 16529614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of oxcarbazepine on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy.
    Koo DL; Hwang KJ; Han SW; Kim JY; Joo EY; Shin WC; Lee HW; Seo DW; Hong SB
    Epilepsy Res; 2014 Mar; 108(3):442-7. PubMed ID: 24507862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The bone mineral content alterations in pediatric patients medicated with levetiracetam, valproic acid, and carbamazepine.
    Serin HM; Koç ZP; Temelli B; Esen İ
    Epilepsy Behav; 2015 Oct; 51():221-4. PubMed ID: 26298867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients.
    Zeng K; Wang X; Xi Z; Yan Y
    Clin Neurol Neurosurg; 2010 May; 112(4):291-5. PubMed ID: 20071075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of long-term antiepileptic drug monotherapy on vascular risk factors and atherosclerosis.
    Chuang YC; Chuang HY; Lin TK; Chang CC; Lu CH; Chang WN; Chen SD; Tan TY; Huang CR; Chan SH
    Epilepsia; 2012 Jan; 53(1):120-8. PubMed ID: 22085257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of topiramate monotherapy on bone mineral density and markers of bone and mineral metabolism in premenopausal women with epilepsy.
    Heo K; Rhee Y; Lee HW; Lee SA; Shin DJ; Kim WJ; Song HK; Song K; Lee BI
    Epilepsia; 2011 Oct; 52(10):1884-9. PubMed ID: 21692779
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy.
    Guo CY; Ronen GM; Atkinson SA
    Epilepsia; 2001 Sep; 42(9):1141-7. PubMed ID: 11580761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone mineral density in adult patients treated with various antiepileptic drugs.
    Beniczky SA; Viken J; Jensen LT; Andersen NB
    Seizure; 2012 Jul; 21(6):471-2. PubMed ID: 22541979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic antiepileptic monotherapy, bone metabolism, and body composition in non-institutionalized children.
    Rauchenzauner M; Griesmacher A; Tatarczyk T; Haberlandt E; Strasak A; Zimmerhackl LB; Falkensammer G; Luef G; Högler W
    Dev Med Child Neurol; 2010 Mar; 52(3):283-8. PubMed ID: 19709134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fracture risk associated with use of antiepileptic drugs.
    Vestergaard P; Rejnmark L; Mosekilde L
    Epilepsia; 2004 Nov; 45(11):1330-7. PubMed ID: 15509233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effect of carbamazepine and valproate on bone metabolism in children with epilepsy].
    Song XQ; Wang ZP; Bao KR; Zhang JM; Wu J; Yan CH; Shen XM
    Zhonghua Er Ke Za Zhi; 2005 Oct; 43(10):728-32. PubMed ID: 16255847
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.
    Välimäki MJ; Tiihonen M; Laitinen K; Tähtelä R; Kärkkäinen M; Lamberg-Allardt C; Mäkelä P; Tunninen R
    J Bone Miner Res; 1994 May; 9(5):631-7. PubMed ID: 8053391
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of bone mineral density in children receiving carbamazepine or valproate monotherapy.
    Chou IJ; Lin KL; Wang HS; Wang CJ
    Acta Paediatr Taiwan; 2007; 48(6):317-22. PubMed ID: 18437965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse effects of antiepileptic drugs on bone mineral density.
    Babayigit A; Dirik E; Bober E; Cakmakci H
    Pediatr Neurol; 2006 Sep; 35(3):177-81. PubMed ID: 16939856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antiepileptic drugs on bone density in ambulatory patients.
    Farhat G; Yamout B; Mikati MA; Demirjian S; Sawaya R; El-Hajj Fuleihan G
    Neurology; 2002 May; 58(9):1348-53. PubMed ID: 12011279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic and hormonal disturbances in women with epilepsy on antiepileptic drug monotherapy.
    Kim JY; Lee HW
    Epilepsia; 2007 Jul; 48(7):1366-70. PubMed ID: 17565596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Long-term Carbamazepine Therapy on Bone Health.
    Suljic EM; Mehicevic A; Mahmutbegovic N
    Med Arch; 2018 Oct; 72(4):262-266. PubMed ID: 30514991
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of conversion to monotherapy with lamotrigine compared with valproate and carbamazepine in patients with epilepsy.
    Fakhoury TA; Hammer AE; Vuong A; Messenheimer JA
    Epilepsy Behav; 2004 Aug; 5(4):532-8. PubMed ID: 15256191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.